Come up with a name for your new list and we'll add to it:
Orthovita raised a round of funding on October 24, 2001. Investors include
Paul Capital Partners.
Orthovita is an orthopedic device company focused on synthetic biomaterials for spine surgery and fracture repair. It sells VITOSS bone graft substitute, an ultra-porous resorbable bone void filler an…